The beneficial effects of FOS supplementation (decrease in hyperglycemia, improvement of insulin sensitivity) in animal models of obesity are reported to be partly linked to an increased expression of proglucagon and production of glucagon-like peptide-1 by endocrine L-cells present in the colon [48]. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.